2025-04-19 - Analysis Report
## Albemarle Corp (ALB) Stock Review

**0. Summary Statistics:**

* **Ticker:** ALB
* **Company:** Albemarle Corp is a leading global producer of lithium and other specialty chemicals.
* **Cumulative Return (ALB):** 5.48%
* **Cumulative Return (VOO):** 76.18%
* **Return Difference (ALB vs VOO):** -70.7%
* **Relative Divergence:** 0.5 (Indicates ALB's performance is in the lower 50th percentile relative to VOO's performance over the historical period considered for the calculation of max and min divergence)


**1. Performance Comparison and Alpha/Beta Analysis:**

Albemarle's cumulative return significantly underperformed the S&P 500 (VOO) over the analyzed period. The substantial negative difference (-70.7%) highlights underperformance.

The provided alpha/beta analysis reveals significant volatility in Albemarle's performance and varying relationships with the market (beta).  While some periods show high CAGR and positive alpha, suggesting outperformance, others show drastic negative returns and high beta, indicating significant market sensitivity. The most recent periods (2022-2025) show extremely negative CAGRs and high beta. This volatility underscores significant risk associated with ALB.

| Year       | CAGR     | MDD      | Alpha | Beta  | Cap(B) |
|------------|----------|----------|-------|-------|--------|
| 2015-2017  | 103.0%   | 7.7%     | 70.0% | 0.1   | 13.7   |
| 2016-2018  | 15.0%    | 58.1%    | -6.0% | 0.1   | 8.4    |
| 2017-2019  | -43.0%   | 58.1%    | -77.0%| 0.6   | 8.1    |
| 2018-2020  | 108.0%   | 62.9%    | 78.0% | 0.9   | 16.6   |
| 2019-2021  | 282.0%   | 62.9%    | 221.0%| 1.0   | 26.5   |
| 2020-2022  | 251.0%   | 75.6%    | 242.0%| 1.0   | 24.8   |
| 2021-2023  | -53.0%   | 77.6%    | -73.0%| 0.7   | 16.6   |
| 2022-2024  | -211.0%  | 77.6%    | -232.0%| 0.8   | 10.1   |
| 2023-2025  | -362.0%  | 77.6%    | -377.0%| 2.1   | 6.2    |


**2. Recent Price Movement:**

* **Closing Price:** $52.91
* **5-Day Moving Average:** $54.71
* **20-Day Moving Average:** $64.71
* **60-Day Moving Average:** $74.19

The price is below all three moving averages, suggesting a downtrend.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.42 (Medium Risk)
* **RSI:** 28.86 (Suggests oversold conditions)
* **PPO:** -1.76 (Suggests bearish momentum)
* **Recent Relative Divergence Change (20-day):** 0.3 (+) (Short-term upward movement)
* **Price Change (Last Market):**  A positive change of $0.65 suggests a minor upward bounce, however this is not significant enough to signal a trend reversal given the overall downtrend and negative technical indicators.
* **Expected Return (2+ years):** 14535.0% (This extremely high figure requires careful scrutiny. The methodology for calculating this needs further clarification as it is unrealistic without additional information.)


**4. Recent Earnings Analysis:**

The earnings data shows significant volatility and recent losses.  Note the repetition of the 2024-11-06 data point.  Further investigation is needed to clarify this discrepancy.

| Date       | EPS       | Revenue      |
|------------|-----------|--------------|
| 2024-11-06 | -9.45     | $1.35 B      |
| 2024-07-31 | -1.96     | $1.43 B      |
| 2024-05-01 | -0.08     | $1.36 B      |
| 2023-11-01 | 2.58      | $2.31 B      |
| 2024-11-06 | 2.58      | $2.31 B      |


**5. Financial Information:**

The financial information reveals a concerning trend of declining revenue and profitability in recent quarters, along with significant fluctuations in equity and ROE.  The negative profit margins and ROE in several quarters are alarming.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31  | $1.23B   | 11.22%        |
| 2024-09-30  | $1.35B   | -7.68%        |
| 2024-06-30  | $1.43B   | -0.74%        |
| 2024-03-31  | $1.36B   | 2.86%         |
| 2023-12-31  | $2.36B   | -29.88%       |

**Capital and Profitability:**

| Quarter     | Equity    | ROE           |
|-------------|-----------|---------------|
| 2024-12-31  | $9.96B    | 0.76%         |
| 2024-09-30  | $10.24B   | -10.44%       |
| 2024-06-30  | $11.22B   | -1.68%        |
| 2024-03-31  | $11.53B   | 0.02%         |
| 2023-12-31  | $9.41B    | -6.56%        |


**6. Overall Analysis:**

Albemarle's performance has been highly volatile and significantly underperformed the S&P 500 recently. Negative earnings and declining profitability raise significant concerns.  While some periods show strong growth, the recent trend is alarming. The high expected return figure needs further justification.  Current technical indicators suggest oversold conditions, but the strong downtrend and negative fundamentals warrant caution.  Further investigation is needed to understand the inconsistencies in the provided data (repeated earnings data point) and the methodology behind the exceptionally high projected long-term return.  Before considering any investment, a thorough review of Albemarle's business model, future growth prospects, and risk factors is crucial.
